Literature DB >> 17334830

Generic and disease-specific health related quality of life of liver patients with various aetiologies: a survey.

Simone M van der Plas1, Bettina E Hansen, Josien B de Boer, Theo Stijnen, Jan Passchier, Rob A de Man, Solko W Schalm.   

Abstract

Most studies on health related quality of life (HRQoL) of chronic liver patients were done in small clinical populations or restricted to one aetiology or disease stage. There is still a need for a study in a large liver patient population with various aetiologies and disease stages, approaching a population-based study. We evaluated the impact of liver disease aetiology on generic HRQoL, disease-specific HRQoL and fatigue and we compared HRQoL and fatigue between aetiological groups and healthy Dutch controls. Members of the Dutch liver patient association completed the Liver Disease Symptom Index, Short Form-36, and Multidimensional Fatigue Index-20. We compared the HRQoL between patients with viral hepatitis, autoimmune hepatitis, cholestatic diseases, hemochromatosis and other liver diseases by linear, ordinal and logistic regression, corrected for disease stage and other significant factors. Viral hepatitis patients showed a worse mental health than other aetiological groups. Hemochromatosis patients demonstrated 17% more bodily pain than viral hepatitis patients and the strongest decrease in role emotional health with increasing age. Aetiological groups showed a worse generic HRQoL and more fatigue than controls. In conclusion, viral hepatitis and hemochromatosis patients have a more impaired HRQoL than patients of other liver disease aetiological groups.

Entities:  

Mesh:

Year:  2006        PMID: 17334830     DOI: 10.1007/s11136-006-9131-y

Source DB:  PubMed          Journal:  Qual Life Res        ISSN: 0962-9343            Impact factor:   4.147


  19 in total

1.  Fatigue and physical function after orthotopic liver transplantation.

Authors:  Mette Aadahl; Bent Adel Hansen; Preben Kirkegaard; Mogens Groenvold
Journal:  Liver Transpl       Date:  2002-03       Impact factor: 5.799

2.  A psychometric comparison of health-related quality of life measures in chronic liver disease.

Authors:  G Unal; J B de Boer; G J Borsboom; J T Brouwer; M Essink-Bot; R A de Man
Journal:  J Clin Epidemiol       Date:  2001-06       Impact factor: 6.437

Review 3.  Hepatitis B virus infection--natural history and clinical consequences.

Authors:  Don Ganem; Alfred M Prince
Journal:  N Engl J Med       Date:  2004-03-11       Impact factor: 91.245

4.  Translation, validation, and norming of the Dutch language version of the SF-36 Health Survey in community and chronic disease populations.

Authors:  N K Aaronson; M Muller; P D Cohen; M L Essink-Bot; M Fekkes; R Sanderman; M A Sprangers; A te Velde; E Verrips
Journal:  J Clin Epidemiol       Date:  1998-11       Impact factor: 6.437

5.  Assessment of utilities and health-related quality of life in patients with chronic liver disease.

Authors:  Z M Younossi; N Boparai; M McCormick; L L Price; G Guyatt
Journal:  Am J Gastroenterol       Date:  2001-02       Impact factor: 10.864

6.  The effects of pain severity on health-related quality of life: a study of Chinese cancer patients.

Authors:  X S Wang; C S Cleeland; T R Mendoza; M C Engstrom; S Liu; G Xu; X Hao; Y Wang; X S Ren
Journal:  Cancer       Date:  1999-11-01       Impact factor: 6.860

7.  The true impact of fatigue in primary biliary cirrhosis: a population study.

Authors:  Jennifer Goldblatt; Philip J S Taylor; Toby Lipman; Martin I Prince; Anna Baragiotta; Margaret F Bassendine; Oliver F W James; David E J Jones
Journal:  Gastroenterology       Date:  2002-05       Impact factor: 22.682

8.  A survey of 2,851 patients with hemochromatosis: symptoms and response to treatment.

Authors:  S M McDonnell; B L Preston; S A Jewell; J C Barton; C Q Edwards; P C Adams; R Yip
Journal:  Am J Med       Date:  1999-06       Impact factor: 4.965

Review 9.  The impact of pain management on quality of life.

Authors:  Nathaniel Katz
Journal:  J Pain Symptom Manage       Date:  2002-07       Impact factor: 3.612

10.  Arthropathy in juvenile hemochromatosis.

Authors:  George Vaiopoulos; George Papanikolaou; Marianna Politou; Iyad Jibreel; Nikos Sakellaropoulos; Dimitris Loukopoulos
Journal:  Arthritis Rheum       Date:  2003-01
View more
  10 in total

1.  An In-Depth Analysis of Patient-Reported Outcomes in Patients With Chronic Hepatitis C Treated With Different Anti-Viral Regimens.

Authors:  Zobair M Younossi; Maria Stepanova; Linda Henry; Fatema Nader; Sharon Hunt
Journal:  Am J Gastroenterol       Date:  2016-03-29       Impact factor: 10.864

2.  Quality of life scores differs between genotypic groups of patients with suspected hereditary hemochromatosis.

Authors:  Paula Fernanda Silva Fonseca; Rodolfo Delfini Cançado; Flavio Augusto Naoum; Carla Luana Dinardo; Guilherme Henrique Hencklain Fonseca; Sandra Fatima Menosi Gualandro; José Eduardo Krieger; Alexandre Costa Pereira; Pierre Brissot; Paulo Caleb Junior Lima Santos
Journal:  BMC Med Genet       Date:  2018-01-05       Impact factor: 2.103

3.  Estimation of utility weights for major liver diseases according to disease severity in Korea.

Authors:  Minsu Ock; So Yun Lim; Hyeon-Jeong Lee; Seon-Ha Kim; Min-Woo Jo
Journal:  BMC Gastroenterol       Date:  2017-09-05       Impact factor: 3.067

4.  Cannabidiol (CBD) Consumption and Perceived Impact on Extrahepatic Symptoms in Patients with Autoimmune Hepatitis.

Authors:  Karan Mathur; Vahin Vuppalanchi; Kayla Gelow; Raj Vuppalanchi; Craig Lammert
Journal:  Dig Dis Sci       Date:  2019-07-30       Impact factor: 3.199

5.  Study protocol: a multicentre, open-label, parallel-group, phase 2, randomised controlled trial of autologous macrophage therapy for liver cirrhosis (MATCH).

Authors:  Paul Noel Brennan; Mark MacMillan; Thomas Manship; Francesca Moroni; Alison Glover; Catriona Graham; Scott Semple; David M Morris; Alasdair R Fraser; Chloe Pass; Neil W A McGowan; Marc L Turner; Neil Lachlan; John F Dillon; John D M Campbell; Jonathan Andrew Fallowfield; Stuart J Forbes
Journal:  BMJ Open       Date:  2021-11-08       Impact factor: 2.692

Review 6.  Health-related quality of life in autoimmune hepatitis.

Authors:  Romée Jalm Snijders; Piotr Milkiewicz; Christoph Schramm; Tom Jg Gevers
Journal:  World J Hepatol       Date:  2021-11-27

7.  Health-related quality of life in patients with autoimmune hepatitis: A questionnaire survey.

Authors:  Atsushi Takahashi; Kei Moriya; Hiromasa Ohira; Teruko Arinaga-Hino; Mikio Zeniya; Takuji Torimura; Masanori Abe; Akinobu Takaki; Jong-Hon Kang; Ayano Inui; Tomoo Fujisawa; Kaname Yoshizawa; Yoshiyuki Suzuki; Nobuhiro Nakamoto; Kazuhiko Koike; Hitoshi Yoshiji; Aya Goto; Atsushi Tanaka; Zobair M Younossi; Hajime Takikawa
Journal:  PLoS One       Date:  2018-10-04       Impact factor: 3.240

8.  Quality of Life Scores Remained Different among the Genotypic Groups of Patients with Suspected Hemochromatosis, Even after Treatment Period.

Authors:  Luis Alfredo Utria Acevedo; Aline Morgan Alvarenga; Paula Fernanda Silva Fonseca; Nathália Kozikas da Silva; Rodolfo Delfini Cançado; Flavio Augusto Naoum; Carla Luana Dinardo; Alexandre Costa Pereira; Pierre Brissot; Paulo Caleb Junior Lima Santos
Journal:  Genes (Basel)       Date:  2022-01-10       Impact factor: 4.096

9.  Health-related quality of life in patients with autoimmune hepatitis.

Authors:  Maurice Michel; Francesca Spinelli; Annette Grambihler; Christian Labenz; Michael Nagel; Leonard Kaps; Yvonne Huber; Peter R Galle; Marcus-Alexander Wörns; Jörn M Schattenberg
Journal:  Qual Life Res       Date:  2021-05-12       Impact factor: 4.147

10.  Quality of life among patients with autoimmune hepatitis in remission: A comparative study.

Authors:  Atsushi Takahashi; Masanori Abe; Tetsuya Yasunaka; Teruko Arinaga-Hino; Kazumichi Abe; Akinobu Takaki; Takuji Torimura; Mikio Zeniya; Kaname Yoshizawea; Jong-Hon Kang; Yoshiyuki Suzuki; Nobuhiro Nakamoto; Ayano Inui; Atsushi Tanaka; Hajime Takikawa; Hiromasa Ohira
Journal:  Medicine (Baltimore)       Date:  2020-10-23       Impact factor: 1.817

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.